← FDA DRUG APPROVALS

FDA ANDA · ANDA075561

CHLORHEXIDINE GLUCONATE, 0.12% ORAL RINSE SOLUTION

Sponsor: BAJAJ

APPLICATION
ANDA075561
TYPE
ANDA
ORIGINAL APPROVAL
2000-11-14
LATEST ACTION
2024-05-24
ROUTE
DENTAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

CHLORHEXIDINE GLUCONATEPrescription
CHLORHEXIDINE GLUCONATE 0.12% · SOLUTION · DENTAL

Approval history

2024-05-24Manufacturing (CMC) · Supplement 16 · unknownAP
2021-11-17Manufacturing (CMC) · Supplement 14 · unknownAP
2020-02-28Labeling · Supplement 8 · standardAP
2001-10-25Labeling · Supplement 2AP
2001-01-26Manufacturing (CMC) · Supplement 1AP
2000-11-14OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →